skip nav
  Home | About CDC | Press Room | A-Z Index | Contact Us
spacer
CDC Centers for Disease Control and Prevention Home Page
CDC en Español
Search:  
CDC Home > HIV/AIDS > Topics > Statistics and Surveillance > Reports > Enhanced Perinatal Surveillance United States, 1999–2001
spacer
spacer spacer
spacer
 
Skip Nav spacer
spacer
Table 11. Receipt of antiretroviral therapy by HIV-infected women and HIV-exposed infants, by timing of receipt, race/ethnicity, and year of infant's birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance
spacer
spacer
View PDF PDF icon
  Year of infant's birth   Subtotal
  1999   2000   2001  
Receipt of antiretroviral therapy No. %   No. %   No. %   No. %
  White, not Hispanic
Prenatal period                      
Yes 294 84   274 85   243 89   811 86
No 37 11   37 12   23 8   97 10
Unknown 21 6   11 3   7 3   39 4
 
Intrapartum period                      
Yes 278 79   261 81   240 88   779 82
No 40 11   31 10   23 8   94 10
Unknown 34 10   30 9   10 4   74 8
 
Neonatal perioda                      
Yes 321 91   301 94   261 96   883 93
No 22 6   17 5   4 2   43 5
Unknown 9 3   4 1   8 3   21 2
 
Total 352     322     273     947 100
  White, not Hispanic
Prenatal period                      
Yes 1569 77   1673 79   1304 80   4546 78
No 391 19   346 16   268 17   1005 17
Unknown 92 5   99 5   57 4   248 4
 
Intrapartum period                      
Yes 1516 74   1634 77   1273 78   4423 76
No 301 15   276 13   211 13   788 14
Unknown 235 12   208 10   145 9   588 10
 
Neonatal perioda                      
Yes 1833 89   1978 93   1512 93   5323 92
No 162 8   94 4   63 4   319 6
Unknown 57 3   46 2   54 3   157 3
 
Total 2052     2118     1629     5799 100
  Hispanic
Prenatal period                      
Yes 338 78   437 82   340 84   1115 81
No 72 17   76 14   50 12   198 14
Unknown 25 6   20 4   16 4   61 4
 
Intrapartum period                      
Yes 331 76   416 78   330 81   1077 78
No 73 17   69 13   51 13   193 14
Unknown 31 7   48 9   25 6   104 8
 
Neonatal perioda                      
Yes 379 87   502 94   387 95   1268 92
No 43 10   21 4   17 4   81 6
Unknown 13 3   10 2   2 1   25 2
 
Totala 435     533     406     1374 100
Note. Because of rounding, column percentages may not total 100. The numbers of women receiving antiretroviral therapy prenatally and intrapartum are not mutually exclusive. Asians/Pacific Islanders and American Indians/Alaska Natives were not included because of small numbers. See Table 4 for cumulative totals of all races.
a Includes 1 HIV-exposed infant per pregnancy with the assumption that all infants of a multiple birth received the same antiretroviral therapy.
Last Modified: September 19, 2006
Last Reviewed: September 19, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
spacer
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.		 spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services